Sustained Release Treatment

搜索文档
EyePoint Pharmaceuticals(EYPT) - 2025 Q1 - Earnings Call Transcript
2025-05-07 21:32
EyePoint Pharmaceuticals (EYPT) Q1 2025 Earnings Call May 07, 2025 08:30 AM ET Company Participants George Elston - Executive VP & CFOJay Duker - President, CEO & DirectorJennifer Kim - Equity Research DirectorRamiro Ribeiro - Chief Medical OfficerKambiz Yazdi - Vice President - Equity ResearchDebanjana Chatterjee - DirectorYigal Nochomovitz - Director Conference Call Participants Tessa Romero - Equity AnalystTyler Van Buren - Managing Director, Senior Biotech Equity Research AnalystYatin Suneja - Senior Ma ...
EyePoint Pharmaceuticals(EYPT) - 2025 Q1 - Earnings Call Transcript
2025-05-07 21:32
EyePoint Pharmaceuticals (EYPT) Q1 2025 Earnings Call May 07, 2025 08:30 AM ET Company Participants George Elston - Executive VP & CFOJay Duker - President, CEO & DirectorJennifer Kim - Equity Research DirectorRamiro Ribeiro - Chief Medical OfficerKambiz Yazdi - Vice President - Equity ResearchDebanjana Chatterjee - DirectorYigal Nochomovitz - Director Conference Call Participants Tessa Romero - Equity AnalystTyler Van Buren - Managing Director, Senior Biotech Equity Research AnalystYatin Suneja - Senior Ma ...
EyePoint Pharmaceuticals(EYPT) - 2025 Q1 - Earnings Call Transcript
2025-05-07 21:30
EyePoint Pharmaceuticals (EYPT) Q1 2025 Earnings Call May 07, 2025 08:30 AM ET Speaker0 Good morning. My name is Towanda, and I'll be your conference operator today. At this time, I would like to welcome everyone to the ICON First Quarter twenty twenty five Financial Results and Recent Corporate Development Conference Call. There will be a question and answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company's risk request. I would ...